Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Parkinson's Disease

Free Subscription Articles published in PLoS One Retrieve available abstracts of 237 articles: HTML format

Single Articles

January 2024
1. KIM M, Kim D, Kang H, Park S, et al
   A machine learning model for prediction of sarcopenia in patients with Parkinson's Disease.
   PLoS One. 2024;19:e0296282.
   PubMed     Abstract available
   
   
   
2. BRUNI F, Mancuso V, Stramba-Badiale C, Stramba-Badiale M, et al
   Beyond traditional training: Integrating data from semi-immersive VR dual-task intervention in Parkinsonian Syndromes. A study protocol.
   PLoS One. 2024;19:e0294199.
   PubMed     Abstract available
   
   
   
3. SOKOLOWSKI A, Bhagwat N, Chatelain Y, Dugre M, et al
   Longitudinal brain structure changes in Parkinson's disease: A replication study.
   PLoS One. 2024;19:e0295069.
   PubMed     Abstract available
   
   
   
4. ESSAWY ESSAWY A, Abou-ElNaga OA, Mehanna RA, Badae NM, et al
   Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies.
   PLoS One. 2024;19:e0296297.
   PubMed     Abstract available
   
   
   
5. WAWRZICZNY E, Flinois B, Constant E, Brugalle E, et al
   Dealing with the diagnosis of Parkinson's disease and its implications for couple functioning in the early stage: An interpretative phenomenological analysis.
   PLoS One. 2024;19:e0294240.
   PubMed     Abstract available
   
   
   
6. MEIJER LL, Ruis C, Schielen ZA, Dijkerman HC, et al
   CT-optimal touch and chronic pain experience in Parkinson's Disease; An intervention study.
   PLoS One. 2024;19:e0298345.
   PubMed     Abstract available
   
   
   
7. TIAN J, Zuo C, Shi J, Ma D, et al
   Peripheral immune cell traits and Parkinson's disease: A Mendelian randomization study.
   PLoS One. 2024;19:e0299026.
   PubMed     Abstract available
   
   
   
8. MALAGUTI MC, Gios L, Giometto B, Longo C, et al
   Artificial intelligence of imaging and clinical neurological data for predictive, preventive and personalized (P3) medicine for Parkinson Disease: The NeuroArtP3 protocol for a multi-center research study.
   PLoS One. 2024;19:e0300127.
   PubMed     Abstract available
   
   
   
9. VARGA I, Bakstein E, Gilmore G, May J, et al
   Statistical segmentation model for accurate electrode positioning in Parkinson's deep brain stimulation based on clinical low-resolution image data and electrophysiology.
   PLoS One. 2024;19:e0298320.
   PubMed     Abstract available
   
   
   
10. SEUTHE J, Heinzel A, Hulzinga F, Ginis P, et al
    Towards a better understanding of anticipatory postural adjustments in people with Parkinson's disease.
    PLoS One. 2024;19:e0300465.
    PubMed     Abstract available
    
    
    
11. SCHRAG A, Kostev K
    Association of antihypertensives and Parkinson's disease in a primary care population matched for underlying diagnosis.
    PLoS One. 2024;19:e0299985.
    PubMed     Abstract available
    
    
    
12. CAI X, Jin Z, Zhang S, Liu J, et al
    Sjogren's syndrome and Parkinson's Disease: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298778.
    PubMed     Abstract available
    
    
    
13. MCMAHON L, McGrath D, Blake C, Lennon O, et al
    Responsiveness of respiratory function in Parkinson's Disease to an integrative exercise programme: A prospective cohort study.
    PLoS One. 2024;19:e0301433.
    PubMed     Abstract available
    
    
    
14. SAADULLAH M, Tariq H, Chauhdary Z, Saleem U, et al
    Biochemical properties and biological potential of Syzygium heyneanum with antiparkinson's activity in paraquat induced rodent model.
    PLoS One. 2024;19:e0298986.
    PubMed     Abstract available
    
    
    
15. KHAN A, Ezeugwa J, Ezeugwu VE
    A systematic review of the associations between sedentary behavior, physical inactivity, and non-motor symptoms of Parkinson's disease.
    PLoS One. 2024;19:e0293382.
    PubMed     Abstract available
    
    
    
16. SONG J, Li J, Pei X, Chen J, et al
    Identification of cuproptosis-realated key genes and pathways in Parkinson's disease via bioinformatics analysis.
    PLoS One. 2024;19:e0299898.
    PubMed     Abstract available
    
    
    
17. ANJUM R, Raza C, Faheem M, Ullah A, et al
    Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions in mouse model of Parkinson's disease through anti-oxidant capacities.
    PLoS One. 2024;19:e0302102.
    PubMed     Abstract available
    
    
    
18. MORACA GAG, Orcioli-Silva D, Legutke BR, Gutierrez PP, et al
    Aerobic exercise on the treadmill combined with transcranial direct current stimulation on the gait of people with Parkinson's disease: A protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0300243.
    PubMed     Abstract available
    
    
    
19. VARGA I, Bakstein E, Gilmore G, May J, et al
    Correction: Statistical segmentation model for accurate electrode positioning in Parkinson's deep brain stimulation based on clinical low-resolution image data and electrophysiology.
    PLoS One. 2024;19:e0302985.
    PubMed     Abstract available
    
    
    
20. TABARI F, Berger JI, Flouty O, Copeland B, et al
    Speech, voice, and language outcomes following deep brain stimulation: A systematic review.
    PLoS One. 2024;19:e0302739.
    PubMed     Abstract available
    
    
    
21. ZHANG HW, Xie J, Peng HC, Lin YS, et al
    Use of antiviral drugs and incidence of Parkinson's disease in Taiwan.
    PLoS One. 2024;19:e0302383.
    PubMed     Abstract available
    
    
    
22. PARK MS, Park S, Kang JY, Jung IC, et al
    The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
    PLoS One. 2024;19:e0303156.
    PubMed     Abstract available
    
    
    
23. ALTHAM C, Zhang H, Pereira E
    Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review.
    PLoS One. 2024;19:e0303644.
    PubMed     Abstract available
    
    
    
24. MILDNER S, Hotz I, Kubler F, Rausch L, et al
    Effects of activity-oriented physiotherapy with and without eye movement training on dynamic balance, functional mobility, and eye movements in patients with Parkinson's disease: An assessor-blinded randomised controlled pilot trial.
    PLoS One. 2024;19:e0304788.
    PubMed     Abstract available
    
    
    
25. HARRIS DM, O'Bryan SJ, Latella C
    Non-invasive brain stimulation as treatment for motor impairment in people with Parkinson's disease: Protocol for an umbrella review.
    PLoS One. 2024;19:e0304717.
    PubMed     Abstract available
    
    
    
26. AGLEY L, Hartley P, Lafortune L
    Exploring the experiences, priorities and preferences of people living with Parkinson's on exercise and physical activity promotion in the UK.
    PLoS One. 2024;19:e0304223.
    PubMed     Abstract available
    
    
    
27. CRIGHTON EJ, Ouedraogo AM, Sawada M, Mestre TA, et al
    Patterns and determinants of health care utilization among people with Parkinson's disease: A population-based analysis in Ontario, Canada.
    PLoS One. 2024;19:e0305062.
    PubMed     Abstract available
    
    
    
28. YALCIN M, Peralta AR, Bentes C, Silva C, et al
    Molecular characterization of the circadian clock in patients with Parkinson's disease-CLOCK4PD Study protocol.
    PLoS One. 2024;19:e0305712.
    PubMed     Abstract available
    
    
    
29. GORJI A, Fathi Jouzdani A
    Machine learning for predicting cognitive decline within five years in Parkinson's disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers.
    PLoS One. 2024;19:e0304355.
    PubMed     Abstract available
    
    
    
30. BOSCH-BARCELO P, Climent-Sanz C, Martinez-Navarro O, Masbernat-Almenara M, et al
    A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson's Disease: Study protocol for a randomized controlled trial.
    PLoS One. 2024;19:e0307304.
    PubMed     Abstract available
    
    
    January 2023
31. 
    Expression of Concern: Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.
    PLoS One. 2023;18:e0280116.
    PubMed    
    
    
    
32. ABRAHAM A, Bay AA, Ni L, Schindler N, et al
    Gender differences in motor and non-motor symptoms in individuals with mild-moderate Parkinson's disease.
    PLoS One. 2023;18:e0272952.
    PubMed     Abstract available
    
    
    
33. MA A, Desai N, Lau KK, Palaniswami M, et al
    Automated measurement of inter-arytenoid distance on 4D laryngeal CT: A validation study.
    PLoS One. 2023;18:e0279927.
    PubMed     Abstract available
    
    
    
34. LONGARDNER K, Wright BA, Alakkas A, You H, et al
    Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis.
    PLoS One. 2023;18:e0278262.
    PubMed     Abstract available
    
    
    
35. HAPUTHANTHIRIGE NKH, Sullivan K, Moyle G, Brauer S, et al
    Effects of dance on gait and dual-task gait in Parkinson's disease.
    PLoS One. 2023;18:e0280635.
    PubMed     Abstract available
    
    
    
36. DUARTE JDS, Alcantara WA, Brito JS, Barbosa LCS, et al
    Physical activity based on dance movements as complementary therapy for Parkinson's disease: Effects on movement, executive functions, depressive symptoms, and quality of life.
    PLoS One. 2023;18:e0281204.
    PubMed     Abstract available
    
    
    
37. CABALLOL N, Bayes A, Prats A, Martin-Baranera M, et al
    Feasibility of a wearable inertial sensor to assess motor complications and treatment in Parkinson's disease.
    PLoS One. 2023;18:e0279910.
    PubMed     Abstract available
    
    
    
38. GOMEZ LF, Morales A, Fierrez J, Orozco-Arroyave JR, et al
    Exploring facial expressions and action unit domains for Parkinson detection.
    PLoS One. 2023;18:e0281248.
    PubMed     Abstract available
    
    
    
39. AVENI K, Ahmed J, Borovsky A, McRae K, et al
    Predictive language comprehension in Parkinson's disease.
    PLoS One. 2023;18:e0262504.
    PubMed     Abstract available
    
    
    
40. MORAITOU M, Sotiroudis G, Papagiannakis N, Ferraz MMJ, et al
    a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy.
    PLoS One. 2023;18:e0277602.
    PubMed     Abstract available
    
    
    
41. BUCHWITZ TM, Ruppert-Junck MC, Greuel A, Maier F, et al
    Exploring impaired self-awareness of motor symptoms in Parkinson's disease: Resting-state fMRI correlates and the connection to mindfulness.
    PLoS One. 2023;18:e0279722.
    PubMed     Abstract available
    
    
    
42. CARRICARTE NARANJO C, Sanchez Luaces C, Pedroso Ibanez I, Machado A, et al
    Beyond shallow feelings of complex affect: Non-motor correlates of subjective emotional experience in Parkinson's disease.
    PLoS One. 2023;18:e0281959.
    PubMed     Abstract available
    
    
    
43. DISMORE L, Montague K, Carvalho L, Guerreiro T, et al
    A protocol for the evaluation of a wearable device for monitoring of symptoms, and cueing for the management of drooling, in people with Parkinson's disease.
    PLoS One. 2023;18:e0280727.
    PubMed     Abstract available
    
    
    
44. SOOD M, Suenkel U, von Thaler AK, Zacharias HU, et al
    Bayesian network modeling of risk and prodromal markers of Parkinson's disease.
    PLoS One. 2023;18:e0280609.
    PubMed     Abstract available
    
    
    
45. OHMICHI T, Kasai T, Shinomoto M, Kitani-Morii F, et al
    Serum leucine-rich alpha2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson's disease.
    PLoS One. 2023;18:e0282153.
    PubMed     Abstract available
    
    
    
46. SEO K, Matunari I, Yamamoto T
    Cerebral cortical thinning in Parkinson's disease depends on the age of onset.
    PLoS One. 2023;18:e0281987.
    PubMed     Abstract available
    
    
    
47. CHUNG JW, Knight CA, Bower AE, Martello JP, et al
    Rate control deficits during pinch grip and ankle dorsiflexion in early-stage Parkinson's disease.
    PLoS One. 2023;18:e0282203.
    PubMed     Abstract available
    
    
    
48. CARVAJAL-OLIVEROS A, Dominguez-Baleon C, Sanchez-Diaz I, Zambrano-Tipan D, et al
    Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment.
    PLoS One. 2023;18:e0282348.
    PubMed     Abstract available
    
    
    
49. ALI DE, Bassam SM, Elatrebi S, Habiba ES, et al
    HR LC-MS/MS metabolomic profiling of Yucca aloifolia fruit and the potential neuroprotective effect on rotenone-induced Parkinson's disease in rats.
    PLoS One. 2023;18:e0282246.
    PubMed     Abstract available
    
    
    
50. TAN QY, Roberts HC, Fraser SDS, Amar K, et al
    What are the modifiable factors of treatment burden and capacity among people with Parkinson's disease and their caregivers: A qualitative study.
    PLoS One. 2023;18:e0283713.
    PubMed     Abstract available
    
    
    
51. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
    Prevalence and nature of self-reported visual complaints in people with Parkinson's disease-Outcome of the Screening Visual Complaints questionnaire.
    PLoS One. 2023;18:e0283122.
    PubMed     Abstract available
    
    
    
52. HWANG KS, Langley J, Tripathi R, Hu XP, et al
    In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
    PLoS One. 2023;18:e0282684.
    PubMed     Abstract available
    
    
    
53. CAMPI M, Peters GW, Toczydlowska D
    Ataxic speech disorders and Parkinson's disease diagnostics via stochastic embedding of empirical mode decomposition.
    PLoS One. 2023;18:e0284667.
    PubMed     Abstract available
    
    
    
54. ANWER DM, Gubinelli F, Kurt YA, Sarauskyte L, et al
    A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates.
    PLoS One. 2023;18:e0284480.
    PubMed     Abstract available
    
    
    
55. ALLWRIGHT M, Mundell H, Sutherland G, Austin P, et al
    Machine learning analysis of the UK Biobank reveals IGF-1 and inflammatory biomarkers predict Parkinson's disease risk.
    PLoS One. 2023;18:e0285416.
    PubMed     Abstract available
    
    
    
56. MACLAGAN LC, Marras C, Sewell IJ, Wu CF, et al
    Trends in health service use among persons with Parkinson's disease by rurality: A population-based repeated cross-sectional study.
    PLoS One. 2023;18:e0285585.
    PubMed     Abstract available
    
    
    
57. HIRANO M, Samukawa M, Isono C, Nagai Y, et al
    The effects of safinamide on dysphagia in Parkinson's disease.
    PLoS One. 2023;18:e0286066.
    PubMed     Abstract available
    
    
    
58. DAS J, Barry G, Walker R, Vitorio R, et al
    The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson's: Is the future digital?
    PLoS One. 2023;18:e0285100.
    PubMed     Abstract available
    
    
    
59. ESCHWEILER M, McCrum C, Giannouli E
    A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
    PLoS One. 2023;18:e0286402.
    PubMed     Abstract available
    
    
    
60. CHAND DA, Scadeng M, Dieriks BV
    Absolute quantification of neuromelanin in formalin-fixed human brains using absorbance spectrophotometry.
    PLoS One. 2023;18:e0288327.
    PubMed     Abstract available
    
    
    
61. MARTINDALE JM, Sarva H, Martino D, Gilbert DL, et al
    Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders.
    PLoS One. 2023;18:e0288408.
    PubMed     Abstract available
    
    
    
62. PARAJULI M, Amara AW, Shaban M
    Deep-learning detection of mild cognitive impairment from sleep electroencephalography for patients with Parkinson's disease.
    PLoS One. 2023;18:e0286506.
    PubMed     Abstract available
    
    
    
63. SORRELL L, Leta V, Barnett A, Stevens K, et al
    Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
    PLoS One. 2023;18:e0285349.
    PubMed     Abstract available
    
    
    
64. ZAMORA-URSULO MA, Perez-Becerra J, Tellez LA, Saderi N, et al
    Reversal of pathological motor behavior in a model of Parkinson's disease by striatal dopamine uncaging.
    PLoS One. 2023;18:e0290317.
    PubMed     Abstract available
    
    
    
65. BRITO SAF, Scianni AA, Silveira BMF, Oliveira ERM, et al
    Effects of high-intensity respiratory muscle training on respiratory muscle strength in individuals with Parkinson's disease: Protocol of a randomized clinical trial.
    PLoS One. 2023;18:e0291051.
    PubMed     Abstract available
    
    
    
66. CROOKS S, Carter G, Wilson CB, Wynne L, et al
    Exploring public perceptions and awareness of Parkinson's disease: A scoping review.
    PLoS One. 2023;18:e0291357.
    PubMed     Abstract available
    
    
    
67. CHIU YS, Wu KJ, Yu SJ, Wu KL, et al
    Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein.
    PLoS One. 2023;18:e0291927.
    PubMed     Abstract available
    
    
    
68. BATTISTA L, Casali M, Brusa L, Radicati FG, et al
    Clinical assessment of a new wearable tool for continuous and objective recording of motor fluctuations and ON/OFF states in patients with Parkinson's disease.
    PLoS One. 2023;18:e0287139.
    PubMed     Abstract available
    
    
    
69. VOLLSTEDT EJ, Madoev H, Aasly A, Ahmad-Annuar A, et al
    Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.
    PLoS One. 2023;18:e0292180.
    PubMed     Abstract available
    
    
    
70. OKEMUO AJ, Gallagher D, Dairo YM
    Effects of rebound exercises on balance and mobility of people with neurological disorders: A systematic review.
    PLoS One. 2023;18:e0292312.
    PubMed     Abstract available
    
    
    
71. GUTOWSKI T, Antkiewicz R, Szlufik S
    Machine learning with optimization to create medicine intake schedules for Parkinson's disease patients.
    PLoS One. 2023;18:e0293123.
    PubMed     Abstract available
    
    
    
72. PADILHA C, Souza R, Grossl FS, Gauer APM, et al
    Physical exercise and its effects on people with Parkinson's disease: Umbrella review.
    PLoS One. 2023;18:e0293826.
    PubMed     Abstract available
    
    
    
73. THANPRASERTSUK S, Phowthongkum P, Hopetrungraung T, Poorirerngpoom C, et al
    Levodopa-induced dyskinesia in early-onset Parkinson's disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand.
    PLoS One. 2023;18:e0293516.
    PubMed     Abstract available
    
    
    
74. LEE SH, Chung KC
    USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.
    PLoS One. 2023;18:e0290371.
    PubMed     Abstract available
    
    
    
75. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
    Pareidolias are a function of visuoperceptual impairment.
    PLoS One. 2023;18:e0293942.
    PubMed     Abstract available
    
    
    
76. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    PubMed     Abstract available
    
    
    
77. SENA IG, Costa AVD, Santos IKD, Araujo DP, et al
    Feasibility and effect of high-intensity training on the progression of motor symptoms in adult individuals with Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293357.
    PubMed     Abstract available
    
    
    
78. MAGANA JC, Deus CM, Baldellou L, Avellanet M, et al
    Investigating the impact of physical activity on mitochondrial function in Parkinson's disease (PARKEX): Study protocol for A randomized controlled clinical trial.
    PLoS One. 2023;18:e0293774.
    PubMed     Abstract available
    
    
    
79. MORADI VASTEGANI S, Khoshnam SE, Ghafouri S, Bakhtiari N, et al
    Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal alpha-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.
    PLoS One. 2023;18:e0294612.
    PubMed     Abstract available
    
    
    
80. XIN G, Niu J, Tian Q, Fu Y, et al
    Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
    PLoS One. 2023;18:e0294984.
    PubMed     Abstract available
    
    
    
81. HONG JT, Jung HK, Lee KJ, Gong EJ, et al
    Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study.
    PLoS One. 2023;18:e0295981.
    PubMed     Abstract available
    
    
    
82. CHEN L, Xin G, He Y, Tian Q, et al
    Study of molecular patterns associated with ferroptosis in Parkinson's disease and its immune signature.
    PLoS One. 2023;18:e0295699.
    PubMed     Abstract available
    
    
    
83. BORGHESI F, Mancuso V, Bruni F, Cremascoli R, et al
    Mental flexibility assessment: A research protocol for patients with Parkinson's Disease and Anorexia Nervosa.
    PLoS One. 2023;18:e0293921.
    PubMed     Abstract available
    
    
    
84. MERCER HM, Nair AM, Ridgel A, Piontkivska H, et al
    Alterations in RNA editing in skeletal muscle following exercise training in individuals with Parkinson's disease.
    PLoS One. 2023;18:e0287078.
    PubMed     Abstract available
    
    
    
85. HATTORI N, Kabata D, Asada S, Kanda T, et al
    Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline.
    PLoS One. 2023;18:e0269969.
    PubMed     Abstract available
    
    
    January 2022
86. HASSIN-BAER S, Cohen OS, Israeli-Korn S, Yahalom G, et al
    Identification of an early-stage Parkinson's disease neuromarker using event-related potentials, brain network analytics and machine-learning.
    PLoS One. 2022;17:e0261947.
    PubMed     Abstract available
    
    
    
87. PAMPHLETT R, Bishop DP
    Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson's disease and co-localises with Lewy bodies.
    PLoS One. 2022;17:e0262464.
    PubMed     Abstract available
    
    
    
88. HATTORI N, Takeda A, Hanya Y, Kitagawa T, et al
    Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan.
    PLoS One. 2022;17:e0262796.
    PubMed     Abstract available
    
    
    
89. GIGUERE-RANCOURT A, Plourde M, Racine E, Couture M, et al
    Goal management training and psychoeducation / mindfulness for treatment of executive dysfunction in Parkinson's disease: A feasibility pilot trial.
    PLoS One. 2022;17:e0263108.
    PubMed     Abstract available
    
    
    
90. DIAZ K, Stegemoller EEL
    Electromyographic measures of asymmetric muscle control of swallowing in Parkinson's disease.
    PLoS One. 2022;17:e0262424.
    PubMed     Abstract available
    
    
    
91. VALKONEN K, Makela JP, Airaksinen K, Nurminen J, et al
    Deep brain stimulation of subthalamic nucleus modulates cortical auditory processing in advanced Parkinson's Disease.
    PLoS One. 2022;17:e0264333.
    PubMed     Abstract available
    
    
    
92. SHABAN M, Amara AW
    Resting-state electroencephalography based deep-learning for the detection of Parkinson's disease.
    PLoS One. 2022;17:e0263159.
    PubMed     Abstract available
    
    
    
93. KELEMEN A, Halasz L, Eross L, Rudas G, et al
    Factors affecting postural instability after more than one-year bilateral subthalamic stimulation in Parkinson's disease: A cross-sectional study.
    PLoS One. 2022;17:e0264114.
    PubMed     Abstract available
    
    
    
94. DISBROW EA, Glassy ND, Dressler EM, Russo K, et al
    Cortical oscillatory dysfunction in Parkinson disease during movement activation and inhibition.
    PLoS One. 2022;17:e0257711.
    PubMed     Abstract available
    
    
    
95. HSU P, Ready EA, Grahn JA
    The effects of Parkinson's disease, music training, and dance training on beat perception and production abilities.
    PLoS One. 2022;17:e0264587.
    PubMed     Abstract available
    
    
    
96. GONZALEZ-CASACUBERTA I, Vilas D, Pont-Sunyer C, Tobias E, et al
    Neuronal induction and bioenergetics characterization of human forearm adipose stem cells from Parkinson's disease patients and healthy controls.
    PLoS One. 2022;17:e0265256.
    PubMed     Abstract available
    
    
    
97. FERRUCCI R, Mameli F, Ruggiero F, Reitano M, et al
    Alternate fluency in Parkinson's disease: A machine learning analysis.
    PLoS One. 2022;17:e0265803.
    PubMed     Abstract available
    
    
    
98. SCHONENBERG A, Prell T
    Measuring quality of life with the Parkinson's Disease Questionnaire-39 in people with cognitive impairment.
    PLoS One. 2022;17:e0266140.
    PubMed     Abstract available
    
    
    
99. LUCIEN F, Benarroch EE, Mullan A, Ali F, et al
    Poly (ADP-Ribose) and alpha-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity.
    PLoS One. 2022;17:e0264446.
    PubMed     Abstract available
    
    
    
100. GULKE E, Alsalem M, Kirsten M, Vettorazzi E, et al
     Comparison of Montreal cognitive assessment and Mattis dementia rating scale in the preoperative evaluation of subthalamic stimulation in Parkinson's disease.
     PLoS One. 2022;17:e0265314.
     PubMed     Abstract available
     
     
     
101. KOH J, Takahashi M, Ohmae Y, Taruya J, et al
     A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson's disease.
     PLoS One. 2022;17:e0266354.
     PubMed     Abstract available
     
     
     
102. RUONALA V, Pekkonen E, Airaksinen O, Kankaanpaa M, et al
     Changes in elbow flexion EMG morphology during adjustment of deep brain stimulator in advanced Parkinson's disease.
     PLoS One. 2022;17:e0266936.
     PubMed     Abstract available
     
     
     
103. JOVANOVIC P, Wang Y, Vit JP, Novinbakht E, et al
     Sustained chemogenetic activation of locus coeruleus norepinephrine neurons promotes dopaminergic neuron survival in synucleinopathy.
     PLoS One. 2022;17:e0263074.
     PubMed     Abstract available
     
     
     
104. VIRBEL-FLEISCHMAN C, Retory Y, Hardy S, Huiban C, et al
     Body-Worn Sensors for Parkinson's disease: A qualitative approach with patients and healthcare professionals.
     PLoS One. 2022;17:e0265438.
     PubMed     Abstract available
     
     
     
105. BAKKER M, Johnson ME, Corre L, Mill DN, et al
     Identifying rates and risk factors for medication errors during hospitalization in the Australian Parkinson's disease population: A 3-year, multi-center study.
     PLoS One. 2022;17:e0267969.
     PubMed     Abstract available
     
     
     
106. MEDINA CA, Vargas E, Munger SJ, Miller JE, et al
     Vocal changes in a zebra finch model of Parkinson's disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathway.
     PLoS One. 2022;17:e0265604.
     PubMed     Abstract available
     
     
     
107. GRAMOTNEV DK, Gramotnev G, Gramotnev A, Summers MJ, et al
     Path analysis of biomarkers for cognitive decline in early Parkinson's disease.
     PLoS One. 2022;17:e0268379.
     PubMed     Abstract available
     
     
     
108. TROISI LOPEZ E, Minino R, Sorrentino P, Manzo V, et al
     Sensitivity to gait improvement after levodopa intake in Parkinson's disease: A comparison study among synthetic kinematic indices.
     PLoS One. 2022;17:e0268392.
     PubMed     Abstract available
     
     
     
109. HILL A, Nantel J
     Sensitivity of discrete symmetry metrics: Implications for metric choice.
     PLoS One. 2022;17:e0268581.
     PubMed     Abstract available
     
     
     
110. SONG J, Lee JH, Choi J, Suh MK, et al
     Detection and differentiation of ataxic and hypokinetic dysarthria in cerebellar ataxia and parkinsonian disorders via wave splitting and integrating neural networks.
     PLoS One. 2022;17:e0268337.
     PubMed     Abstract available
     
     
     
111. LANDES RD, Glover A, Pillai L, Doerhoff S, et al
     Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype.
     PLoS One. 2022;17:e0269227.
     PubMed     Abstract available
     
     
     
112. ZINNEN AD, Vichich J, Metzger JM, Gambardella JC, et al
     Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum.
     PLoS One. 2022;17:e0269190.
     PubMed     Abstract available
     
     
     
113. CHONG-WEN W, Sha-Sha L, Xu E
     Predictors of rapid eye movement sleep behavior disorder in patients with Parkinson's disease based on random forest and decision tree.
     PLoS One. 2022;17:e0269392.
     PubMed     Abstract available
     
     
     
114. MARKOVIC V, Stankovic I, Radovanovic S, Petrovic I, et al
     Gait alterations in Parkinson's disease at the stage of hemiparkinsonism-A longitudinal study.
     PLoS One. 2022;17:e0269886.
     PubMed     Abstract available
     
     
     
115. GOLINSKA PB, Bieleninik L, Harciarek M, Bidzan M, et al
     The impact of cognitive impairment of individuals with Parkinson's disease on their caregivers' mental health: A systematic review protocol.
     PLoS One. 2022;17:e0271480.
     PubMed     Abstract available
     
     
     
116. LI L, Ji B, Zhao T, Cui X, et al
     The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments.
     PLoS One. 2022;17:e0269787.
     PubMed     Abstract available
     
     
     
117. READ J, Frost R, Walters K, Tuijt R, et al
     Transitions and challenges for people with Parkinson's and their family members: A qualitative study.
     PLoS One. 2022;17:e0268588.
     PubMed     Abstract available
     
     
     
118. SONG MK, Adams L, Lee JH, Kim YS, et al
     NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-alpha-synuclein mouse model of Parkinson's disease.
     PLoS One. 2022;17:e0272085.
     PubMed     Abstract available
     
     
     
119. HILL MA, Bentley SR, Walker TL, Mellick GD, et al
     Does a rare mutation in PTPRA contribute to the development of Parkinson's disease in an Australian multi-incident family?
     PLoS One. 2022;17:e0271499.
     PubMed     Abstract available
     
     
     
120. HEARN R, Selfe J, Cordero MI, Dobbin N, et al
     The effects of active rehabilitation on symptoms associated with tau pathology: An umbrella review. Implications for chronic traumatic encephalopathy symptom management.
     PLoS One. 2022;17:e0271213.
     PubMed     Abstract available
     
     
     
121. SONG S, Luo Z, Li C, Huang X, et al
     Depressive symptoms before and after Parkinson's diagnosis-A longitudinal analysis.
     PLoS One. 2022;17:e0272315.
     PubMed     Abstract available
     
     
     
122. CHEN HC, Wang CY, Chen HH, Liou HH, et al
     Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson's disease when considering the coexisting effects of diabetes mellitus.
     PLoS One. 2022;17:e0269006.
     PubMed     Abstract available
     
     
     
123. SHAH R, Read J, Davies N, Nimmons D, et al
     People with Parkinson's perspectives and experiences of self-management: Qualitative findings from a UK study.
     PLoS One. 2022;17:e0273428.
     PubMed     Abstract available
     
     
     
124. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
     The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
     PLoS One. 2022;17:e0272559.
     PubMed     Abstract available
     
     
     
125. SNODERLY-FOSTER LJ, Olivas WM
     Regulation of Parkinson's disease-associated genes by Pumilio proteins and microRNAs in SH-SY5Y neuronal cells.
     PLoS One. 2022;17:e0275235.
     PubMed     Abstract available
     
     
     
126. DAS J, Morris R, Barry G, Vitorio R, et al
     Exploring the feasibility of technological visuo-cognitive training in Parkinson's: Study protocol for a pilot randomised controlled trial.
     PLoS One. 2022;17:e0275738.
     PubMed     Abstract available
     
     
     
127. BARCENAS R, Fuentes-Garcia R, Naranjo L
     Mixed kernel SVR addressing Parkinson's progression from voice features.
     PLoS One. 2022;17:e0275721.
     PubMed     Abstract available
     
     
     
128. RAZALI K, Mohd Nasir MH, Othman N, Doolaanea AA, et al
     Characterization of neurobehavioral pattern in a zebrafish 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced model: A 96-hour behavioral study.
     PLoS One. 2022;17:e0274844.
     PubMed     Abstract available
     
     
     
129. TORRADO JC, Husebo BS, Allore HG, Erdal A, et al
     Digital phenotyping by wearable-driven artificial intelligence in older adults and people with Parkinson's disease: Protocol of the mixed method, cyclic ActiveAgeing study.
     PLoS One. 2022;17:e0275747.
     PubMed     Abstract available
     
     
     
130. DE GOES MCR, Sarmento A, Lima I, Lyra M, et al
     After-effects of thixotropic conditionings on operational chest wall and compartmental volumes of patients with Parkinson's disease.
     PLoS One. 2022;17:e0275584.
     PubMed     Abstract available
     
     
     
131. MIKOLAIZAK AS, Rochester L, Maetzler W, Sharrack B, et al
     Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocol.
     PLoS One. 2022;17:e0269615.
     PubMed     Abstract available
     
     
     
132. BAKER S, Tekriwal A, Felsen G, Christensen E, et al
     Automatic extraction of upper-limb kinematic activity using deep learning-based markerless tracking during deep brain stimulation implantation for Parkinson's disease: A proof of concept study.
     PLoS One. 2022;17:e0275490.
     PubMed     Abstract available
     
     
     
133. WAIRAGKAR M, Villeneuve E, King R, Janko B, et al
     A novel approach for modelling and classifying sit-to-stand kinematics using inertial sensors.
     PLoS One. 2022;17:e0264126.
     PubMed     Abstract available
     
     
     
134. LAMA J, Salabasidou E, Volkmann J, Kuzkina A, et al
     Proinflammatory profile in the skin of Parkinson's disease patients with and without pain.
     PLoS One. 2022;17:e0276564.
     PubMed     Abstract available
     
     
     
135. LOWIT A, Thies T, Steffen J, Scheele F, et al
     Task-based profiles of language impairment and their relationship to cognitive dysfunction in Parkinson's disease.
     PLoS One. 2022;17:e0276218.
     PubMed     Abstract available
     
     
     
136. OWEN CL, Gaulton C, Roberts HC, Dennison L, et al
     Perceptions of people with Parkinson's and their caregivers of falling and falls-related healthcare services- a qualitative study.
     PLoS One. 2022;17:e0276588.
     PubMed     Abstract available
     
     
     
137. KOMAGAMINE T, Suzuki K, Kokubun N, Komagamine J, et al
     Sleep-related hallucinations in patients with Parkinson's disease.
     PLoS One. 2022;17:e0276736.
     PubMed     Abstract available
     
     
     
138. 
     Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
     PLoS One. 2022;17:e0277781.
     PubMed     Abstract available
     
     
     
139. BEK J, Leventhal D, Groves M, Growcott C, et al
     Moving online: Experiences and potential benefits of digital dance for older adults and people with Parkinson's disease.
     PLoS One. 2022;17:e0277645.
     PubMed     Abstract available
     
     
     
140. VITORIO R, Morris R, Das J, Walker R, et al
     Brain activity response to cues during gait in Parkinson's disease: A study protocol.
     PLoS One. 2022;17:e0275894.
     PubMed     Abstract available
     
     
     
141. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
     Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
     PLoS One. 2022;17:e0278279.
     PubMed     Abstract available
     
     
     
142. JOLA C, Sundstrom M, McLeod J
     Benefits of dance for Parkinson's: The music, the moves, and the company.
     PLoS One. 2022;17:e0265921.
     PubMed     Abstract available
     
     
     
143. DIERIKS BV, Highet B, Alik A, Bellande T, et al
     Human pericytes degrade diverse alpha-synuclein aggregates.
     PLoS One. 2022;17:e0277658.
     PubMed     Abstract available
     
     
     
144. RAJA WK, Neves E, Burke C, Jiang X, et al
     Patient-derived three-dimensional cortical neurospheres to model Parkinson's disease.
     PLoS One. 2022;17:e0277532.
     PubMed     Abstract available
     
     
     
145. HATORI Y, Kanda Y, Nonaka S, Nakanishi H, et al
     ATP13A2 modifies mitochondrial localization of overexpressed TOM20 to autolysosomal pathway.
     PLoS One. 2022;17:e0276823.
     PubMed     Abstract available
     
     
     
146. NADEEM H, Zhou B, Goldman D, Romley J, et al
     Association between use of ss2-adrenergic receptor agonists and incidence of Parkinson's disease: Retrospective cohort analysis.
     PLoS One. 2022;17:e0276368.
     PubMed     Abstract available
     
     
     
147. SHINOHARA M, Yokoi K, Hirayama K, Kanno S, et al
     Mirror writing and cortical hypometabolism in Parkinson's disease.
     PLoS One. 2022;17:e0279007.
     PubMed     Abstract available
     
     
     
148. OIZUMI H, Sugimura Y, Totsune T, Kawasaki I, et al
     Plasma sphingolipid abnormalities in neurodegenerative diseases.
     PLoS One. 2022;17:e0279315.
     PubMed     Abstract available
     
     
     
149. OGAWA T, Kajiyama Y, Ishido H, Chiba S, et al
     Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkinson's disease: A retrospective study.
     PLoS One. 2022;17:e0279747.
     PubMed     Abstract available
     
     
     January 2021
150. BOUSSAC M, Arbus C, Dupouy J, Harroch E, et al
     Personality dimensions of patients can change during the course of parkinson's disease.
     PLoS One. 2021;16:e0245142.
     PubMed     Abstract available
     
     
     
151. KAMIENIARZ A, Michalska J, Marszalek W, Stania M, et al
     Detection of postural control in early Parkinson's disease: Clinical testing vs. modulation of center of pressure.
     PLoS One. 2021;16:e0245353.
     PubMed     Abstract available
     
     
     
152. KITANI-MORII F, Kasai T, Horiguchi G, Teramukai S, et al
     Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan.
     PLoS One. 2021;16:e0245864.
     PubMed     Abstract available
     
     
     
153. SHALASH AS, Hamid E, Elrassas H, Bahbah EI, et al
     Non-motor symptoms in essential tremor, akinetic rigid and tremor-dominant subtypes of Parkinson's disease.
     PLoS One. 2021;16:e0245918.
     PubMed     Abstract available
     
     
     
154. FORNS J, Layton JB, Bartsch J, Turner ME, et al
     Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
     PLoS One. 2021;16:e0246121.
     PubMed     Abstract available
     
     
     
155. PARK KH, Sun S, Lim YH, Park HR, et al
     Clinical outcome prediction from analysis of microelectrode recordings using deep learning in subthalamic deep brain stimulation for Parkinson`s disease.
     PLoS One. 2021;16:e0244133.
     PubMed     Abstract available
     
     
     
156. MAHMOUDZADEH M, Wallois F, Tir M, Krystkowiak P, et al
     Cortical hemodynamic mapping of subthalamic nucleus deep brain stimulation in Parkinsonian patients, using high-density functional near-infrared spectroscopy.
     PLoS One. 2021;16:e0245188.
     PubMed     Abstract available
     
     
     
157. LIN I, Edison B, Mantri S, Albert S, et al
     Triggers and alleviating factors for fatigue in Parkinson's disease.
     PLoS One. 2021;16:e0245285.
     PubMed     Abstract available
     
     
     
158. SICA M, Tedesco S, Crowe C, Kenny L, et al
     Continuous home monitoring of Parkinson's disease using inertial sensors: A systematic review.
     PLoS One. 2021;16:e0246528.
     PubMed     Abstract available
     
     
     
159. OVEISGHARAN S, Yu L, Bennett DA, Buchman AS, et al
     Incident mobility disability, parkinsonism, and mortality in community-dwelling older adults.
     PLoS One. 2021;16:e0246206.
     PubMed     Abstract available
     
     
     
160. NAGANO T, Kakuma T, Umezu Y, Yanagawa T, et al
     Nutritional status and activities of daily living in patients with Parkinson's disease.
     PLoS One. 2021;16:e0246329.
     PubMed     Abstract available
     
     
     
161. BURIL J, Burilova P, Pokorna A, Kovacova I, et al
     Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study.
     PLoS One. 2021;16:e0246342.
     PubMed     Abstract available
     
     
     
162. 
     Retraction: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats.
     PLoS One. 2021;16:e0247151.
     PubMed    
     
     
     
163. LEE JW, Song YS, Kim H, Ku BD, et al
     Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson's disease: Analysis of the PPMI data.
     PLoS One. 2021;16:e0246881.
     PubMed     Abstract available
     
     
     
164. IIJIMA M, Okuma Y, Suzuki K, Yoshii F, et al
     Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson's disease: A multicenter cross-sectional study.
     PLoS One. 2021;16:e0247443.
     PubMed     Abstract available
     
     
     
165. VARRECCHIA T, Castiglia SF, Ranavolo A, Conte C, et al
     An artificial neural network approach to detect presence and severity of Parkinson's disease via gait parameters.
     PLoS One. 2021;16:e0244396.
     PubMed     Abstract available
     
     
     
166. AGURTO C, Heisig S, Abrami A, Ho BK, et al
     Parkinson's disease medication state and severity assessment based on coordination during walking.
     PLoS One. 2021;16:e0244842.
     PubMed     Abstract available
     
     
     
167. BARGIOTAS I, Kalogeratos A, Limnios M, Vidal PP, et al
     Revealing posturographic profile of patients with Parkinsonian syndromes through a novel hypothesis testing framework based on machine learning.
     PLoS One. 2021;16:e0246790.
     PubMed     Abstract available
     
     
     
168. DZIECIOL K, Iordanishvili E, Abbas Z, Nahimi A, et al
     A robust method for the detection of small changes in relaxation parameters and free water content in the vicinity of the substantia nigra in Parkinson's disease patients.
     PLoS One. 2021;16:e0247552.
     PubMed     Abstract available
     
     
     
169. JEONG S, Cho H, Kim YJ, Ma HI, et al
     Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson's disease.
     PLoS One. 2021;16:e0247354.
     PubMed     Abstract available
     
     
     
170. PHAM U, Skogseid IM, Pripp AH, Boen E, et al
     Impulsivity in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation-An exploratory study.
     PLoS One. 2021;16:e0248568.
     PubMed     Abstract available
     
     
     
171. MANTRI S, Klawson E, Albert S, Rapoport R, et al
     The experience of care partners of patients with Parkinson's disease psychosis.
     PLoS One. 2021;16:e0248968.
     PubMed     Abstract available
     
     
     
172. SEBATE B, Cuttler K, Cloete R, Britz M, et al
     Prioritization of candidate genes for a South African family with Parkinson's disease using in-silico tools.
     PLoS One. 2021;16:e0249324.
     PubMed     Abstract available
     
     
     
173. LOVEGROVE CJ, Bannigan K
     What is the lived experience of anxiety for people with Parkinson's? A phenomenological study.
     PLoS One. 2021;16:e0249390.
     PubMed     Abstract available
     
     
     
174. SIRAGY T, Hill A, Nantel J
     Recovery of dynamic stability during slips unaffected by arm swing in people with Parkinson's Disease.
     PLoS One. 2021;16:e0249303.
     PubMed     Abstract available
     
     
     
175. 
     Correction: A genetic analysis of a Spanish population with early onset Parkinson's disease.
     PLoS One. 2021;16:e0249805.
     PubMed     Abstract available
     
     
     
176. JENSEN BR, Malling ASB, Schmidt SI, Meyer M, et al
     Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson's disease.
     PLoS One. 2021;16:e0248800.
     PubMed     Abstract available
     
     
     
177. SORBERA C, Brigandi A, Cimino V, Bonanno L, et al
     The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.
     PLoS One. 2021;16:e0251313.
     PubMed     Abstract available
     
     
     
178. KROTINGER A, Loui P
     Rhythm and groove as cognitive mechanisms of dance intervention in Parkinson's disease.
     PLoS One. 2021;16:e0249933.
     PubMed     Abstract available
     
     
     
179. LOLEKHA P, Sriphanom T, Vilaichone RK
     Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial).
     PLoS One. 2021;16:e0251042.
     PubMed     Abstract available
     
     
     
180. FREIDLE M, Johansson H, Lebedev AV, Ekman U, et al
     Measuring implicit sequence learning and dual task ability in mild to moderate Parkinson s disease: A feasibility study.
     PLoS One. 2021;16:e0251849.
     PubMed     Abstract available
     
     
     
181. SHRESTHA S, Parks CG, Richards-Barber M, Chen H, et al
     Parkinson's disease case ascertainment in a large prospective cohort.
     PLoS One. 2021;16:e0251852.
     PubMed     Abstract available
     
     
     
182. MCKAY JL, Lang KC, Bong SM, Hackney ME, et al
     Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease.
     PLoS One. 2021;16:e0252119.
     PubMed     Abstract available
     
     
     
183. RODRIGUEZ-SABATE C, Rodriguez M, Morales I
     Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson's disease.
     PLoS One. 2021;16:e0252565.
     PubMed     Abstract available
     
     
     
184. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
     Correction: Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
     PLoS One. 2021;16:e0252988.
     PubMed     Abstract available
     
     
     
185. SHENG MZ, Fang TC, Chen YH, Chang MH, et al
     Is either anosmia or constipation associated with cognitive dysfunction in Parkinson's disease?
     PLoS One. 2021;16:e0252451.
     PubMed     Abstract available
     
     
     
186. CARTER B, Hayes C, Smith A, Pennington A, et al
     A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
     PLoS One. 2021;16:e0251484.
     PubMed     Abstract available
     
     
     
187. RHEW SH, Kravchenko J, Lyerly HK
     Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
     PLoS One. 2021;16:e0253253.
     PubMed     Abstract available
     
     
     
188. PEARCE P, Bulluss K, Xu SS, Kim B, et al
     How accurately are subthalamic nucleus electrodes implanted relative to the ideal stimulation location for Parkinson's disease?
     PLoS One. 2021;16:e0254504.
     PubMed     Abstract available
     
     
     
189. KOYANAGI Y, Fukushi I, Nakamura M, Suzuki K, et al
     The effect of body weight-supported overground gait training for patients with Parkinson's disease: A retrospective case-control observational study.
     PLoS One. 2021;16:e0254415.
     PubMed     Abstract available
     
     
     
190. TAGUCHI S, Koide H, Oiwa H, Hayashi M, et al
     Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
     PLoS One. 2021;16:e0255274.
     PubMed     Abstract available
     
     
     
191. VACCARI C, Grotto D, Pereira TDV, de Camargo JLV, et al
     GLP-1 and GIP receptor agonists in the treatment of Parkinson's disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies.
     PLoS One. 2021;16:e0255726.
     PubMed     Abstract available
     
     
     
192. WARDEN MN, Searles Nielsen S, Camacho-Soto A, Garnett R, et al
     A comparison of prediction approaches for identifying prodromal Parkinson disease.
     PLoS One. 2021;16:e0256592.
     PubMed     Abstract available
     
     
     
193. ARISTOTELIDOU V, Tsatali M, Overton PG, Vivas AB, et al
     Autonomic factors do not underlie the elevated self-disgust levels in Parkinson's disease.
     PLoS One. 2021;16:e0256144.
     PubMed     Abstract available
     
     
     
194. BRAKEDAL B, Tzoulis C, Tysnes OB, Haugarvoll K, et al
     NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study.
     PLoS One. 2021;16:e0256602.
     PubMed     Abstract available
     
     
     
195. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
     Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
     PLoS One. 2021;16:e0257372.
     PubMed     Abstract available
     
     
     
196. PARDOEL S, Shalin G, Lemaire ED, Kofman J, et al
     Grouping successive freezing of gait episodes has neutral to detrimental effect on freeze detection and prediction in Parkinson's disease.
     PLoS One. 2021;16:e0258544.
     PubMed     Abstract available
     
     
     
197. AOUN K, Double KL, Pearson-Dennett V, Yilmaz R, et al
     Measurement of the adult human midbrain with transcranial ultrasound.
     PLoS One. 2021;16:e0247920.
     PubMed     Abstract available
     
     
     
198. MA A, Lau KK, Thyagarajan D
     Radiological correlates of vocal fold bowing as markers of Parkinson's disease progression: A cross-sectional study utilizing dynamic laryngeal CT.
     PLoS One. 2021;16:e0258786.
     PubMed     Abstract available
     
     
     
199. AHN JH, Seok JM, Park J, Jeong H, et al
     Validation of the Korean version of the composite autonomic symptom scale 31 in patients with Parkinson's disease.
     PLoS One. 2021;16:e0258897.
     PubMed     Abstract available
     
     
     
200. PRELL T, Liebermann JD, Mendorf S, Lehmann T, et al
     Pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study.
     PLoS One. 2021;16:e0257966.
     PubMed     Abstract available
     
     
     
201. BAILEY DK, Clark W, Kosman DJ
     The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
     PLoS One. 2021;16:e0254794.
     PubMed     Abstract available
     
     
     
202. NEJTEK VA, James RN, Salvatore MF, Alphonso HM, et al
     Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease.
     PLoS One. 2021;16:e0258851.
     PubMed     Abstract available
     
     
     
203. SHAMADYKOVA DV, Panteleev DY, Kust NN, Savchenko EA, et al
     Neuroinductive properties of mGDNF depend on the producer, E. Coli or human cells.
     PLoS One. 2021;16:e0258289.
     PubMed     Abstract available
     
     
     
204. ELFARRASH S, Jensen NM, Ferreira N, Schmidt SI, et al
     Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
     PLoS One. 2021;16:e0252635.
     PubMed     Abstract available
     
     
     
205. WITT VD, Baur G, Ecke J, Kirchner A, et al
     Parkinson's patients situation during the SARS CoV-2 pandemic and their interest in telemedicine A cross-sectional study.
     PLoS One. 2021;16:e0260317.
     PubMed     Abstract available
     
     
     
206. DEL PINO R, Murueta-Goyena A, Ayala U, Acera M, et al
     Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease.
     PLoS One. 2021;16:e0259935.
     PubMed     Abstract available
     
     
     
207. RICHARD P, Kozlowski L, Guillorit H, Garnier P, et al
     Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.
     PLoS One. 2021;16:e0253216.
     PubMed     Abstract available
     
     
     
208. HAYNES JM, Sibuea SM, Aguiar AA, Li F, et al
     Inhibition of beta-catenin dependent WNT signalling upregulates the transcriptional repressor NR0B1 and downregulates markers of an A9 phenotype in human embryonic stem cell-derived dopaminergic neurons: Implications for Parkinson's disease.
     PLoS One. 2021;16:e0261730.
     PubMed     Abstract available
     
     
     
209. VIRAMETEEKUL S, Phokaewvarangkul O, Bhidayasiri R
     Profiling the most elderly parkinson's disease patients: Does age or disease duration matter?
     PLoS One. 2021;16:e0261302.
     PubMed     Abstract available
     
     
     
210. CUBO E, Garcia-Bustillo A, Arnaiz-Gonzalez A, Ramirez-Sanz JM, et al
     Adopting a multidisciplinary telemedicine intervention for fall prevention in Parkinson's disease. Protocol for a longitudinal, randomized clinical trial.
     PLoS One. 2021;16:e0260889.
     PubMed     Abstract available
     
     
     
211. FRANSSON PA, Nilsson MH, Rehncrona S, Tjernstrom F, et al
     Deep brain stimulation in the subthalamic nuclei alters postural alignment and adaptation in Parkinson's disease.
     PLoS One. 2021;16:e0259862.
     PubMed     Abstract available
     
     
     
212. MAKAI-BOLONI S, Thijssen E, van Brummelen EMJ, Groeneveld GJ, et al
     Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performance.
     PLoS One. 2021;16:e0260783.
     PubMed     Abstract available
     
     
     
213. FRANKEMOLLE-GILBERT AM, Howell B, Bower KL, Veltink PH, et al
     Comparison of methodologies for modeling directional deep brain stimulation electrodes.
     PLoS One. 2021;16:e0260162.
     PubMed     Abstract available
     
     
     January 2020
214. GAARE JJ, Nido G, Dolle C, Sztromwasser P, et al
     Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci.
     PLoS One. 2020;15:e0239824.
     PubMed     Abstract available
     
     
     
215. SATO K, Mano T, Iwata A, Toda T, et al
     Autocorrelation-based method to identify disordered rhythm in Parkinson's disease tasks: A novel approach applicable to multimodal devices.
     PLoS One. 2020;15:e0238486.
     PubMed     Abstract available
     
     
     
216. MONSELLIER E, Bendifallah M, Redeker V, Melki R, et al
     Polypeptides derived from alpha-Synuclein binding partners to prevent alpha-Synuclein fibrils interaction with and take-up by cells.
     PLoS One. 2020;15:e0237328.
     PubMed     Abstract available
     
     
     
217. GLASS TJ, Kelm-Nelson CA, Szot JC, Lake JM, et al
     Functional characterization of extrinsic tongue muscles in the Pink1-/- rat model of Parkinson disease.
     PLoS One. 2020;15:e0240366.
     PubMed     Abstract available
     
     
     
218. TANAKA R, Yamashiro K, Ogawa T, Oyama G, et al
     The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson's disease.
     PLoS One. 2020;15:e0240491.
     PubMed     Abstract available
     
     
     
219. KUBOTA M, Kobayashi N, Sugizaki T, Shimoda M, et al
     Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease.
     PLoS One. 2020;15:e0240448.
     PubMed     Abstract available
     
     
     
220. MORI Y, Yoshikawa E, Futatsubashi M, Ouchi Y, et al
     Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction.
     PLoS One. 2020;15:e0240998.
     PubMed     Abstract available
     
     
     
221. 
     Retraction: Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and Neurturin In Vitro: Potential therapeutic application for Parkinson's disease in a rhesus monkey model.
     PLoS One. 2020;15:e0242032.
     PubMed    
     
     
     
222. JENG B, Cederberg KLJ, Lai B, Sasaki JE, et al
     Accelerometer output and its association with energy expenditure in persons with mild-to-moderate Parkinson's disease.
     PLoS One. 2020;15:e0242136.
     PubMed     Abstract available
     
     
     
223. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
     A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
     PLoS One. 2020;15:e0240855.
     PubMed     Abstract available
     
     
     
224. MALINOVA V, Pinter A, Dragaescu C, Rohde V, et al
     The role of intraoperative microelectrode recording and stimulation in subthalamic lead placement for Parkinson's disease.
     PLoS One. 2020;15:e0241752.
     PubMed     Abstract available
     
     
     
225. MURUGAPPAN M, Alshuaib W, Bourisly AK, Khare SK, et al
     Tunable Q wavelet transform based emotion classification in Parkinson's disease using Electroencephalography.
     PLoS One. 2020;15:e0242014.
     PubMed     Abstract available
     
     
     
226. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
     Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
     PLoS One. 2020;15:e0243051.
     PubMed     Abstract available
     
     
     
227. PINTO C, Salazar AP, Hennig EM, Kerr G, et al
     Dual-task walking reduces lower limb range of motion in individuals with Parkinson's disease and freezing of gait: But does it happen during what events through the gait cycle?
     PLoS One. 2020;15:e0243133.
     PubMed     Abstract available
     
     
     
228. BAUMANN-VOGEL H, Hor H, Poryazova R, Valko P, et al
     REM sleep behavior in Parkinson disease: Frequent, particularly with higher age.
     PLoS One. 2020;15:e0243454.
     PubMed     Abstract available
     
     
     
229. ANDERSSON N, Nilsson MH, Slaug B, Oswald F, et al
     The meaning of home questionnaire revisited: Psychometric analyses among people with Parkinson's disease reveals new dimensions.
     PLoS One. 2020;15:e0242792.
     PubMed     Abstract available
     
     
     
230. TORTI M, Fossati C, Casali M, De Pandis MF, et al
     Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study.
     PLoS One. 2020;15:e0243612.
     PubMed     Abstract available
     
     
     
231. PETROZZIELLO T, Dios AM, Mueller KA, Vaine CA, et al
     SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
     PLoS One. 2020;15:e0243655.
     PubMed     Abstract available
     
     
     
232. POLAKOVA K, Ruzicka E, Jech R, Kemlink D, et al
     3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson's disease treated with DBS of the STN.
     PLoS One. 2020;15:e0244676.
     PubMed     Abstract available
     
     
     
233. IBRAHIM A, Ali RAR, Manaf MRA, Ahmad N, et al
     Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial.
     PLoS One. 2020;15:e0244680.
     PubMed     Abstract available
     
     
     
234. SHIM M, Bang WJ, Oh CY, Lee YS, et al
     Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study.
     PLoS One. 2020;15:e0244660.
     PubMed     Abstract available
     
     
     
235. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
     Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
     PLoS One. 2020;15:e0244776.
     PubMed     Abstract available
     
     
     
236. EHLEN F, Al-Fatly B, Kuhn AA, Klostermann F, et al
     Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson's disease.
     PLoS One. 2020;15:e0244148.
     PubMed     Abstract available
     
     
     
237. PRAVEEN RAJNEESH C, Liou JC, Hsieh TH, Lin JH, et al
     The voiding efficiency in rat models with dopaminergic brain lesions induced through unilateral and bilateral intrastriatal injections.
     PLoS One. 2020;15:e0243452.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.